Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengjun Ji

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Plos One|January 3, 2024
SSC: The novel self-stack ensemble model for thyroid disease predictionShengjun Ji
Translational Cancer Research|February 4, 2022
Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signalingShang Cai, Qingqing Chen, Yingying Xu, et al.
Journal of Inflammation Research|November 17, 2025
A Multicenter Study of Systemic Inflammatory Biomarkers for Prognostic Evaluation in iCCA PatientsYun Tao, Benjie Xu, Jie Tang, et al.
Frontiers in Immunology|November 18, 2024
Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancerJingjing Li, Qingqing Chen, Zhengcao Liu, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|July 2, 2016
[Hypoxia combined with TNF-α induces apoptosis of cultured human pulmonary microvascular endothelial cells via activation of the STAT3 rather than ERK1/2 signaling pathway]Shengjun Ji, Yeliang Wen, Qiting Lai, et al.
Translational Cancer Research|November 11, 2024
Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signalingShang Cai, Qingqing Chen, Yingying Xu, et al.
Scientific Reports|May 30, 2024
A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinomaShanshan Li, Zhengcao Liu, Qingqing Chen, et al.
World Journal of Surgical Oncology|February 21, 2024
Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinomaDanqi Qian, Peipei Shen, Jiahao Zhu, et al.
Discover Oncology|May 16, 2026
A multicenter study identifies an immune inflammatory and nutritional prognostic signature in intrahepatic cholangiocarcinomaJie Tang, Benjie Xu, Yun Tao, et al.
Annals of Medicine|April 3, 2025
Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patientsYingying Xu, Jinping Li, Xiang Ji, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Plos One|January 3, 2024
SSC: The novel self-stack ensemble model for thyroid disease predictionShengjun Ji
Translational Cancer Research|February 4, 2022
Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signalingShang Cai, Qingqing Chen, Yingying Xu, et al.
Journal of Inflammation Research|November 17, 2025
A Multicenter Study of Systemic Inflammatory Biomarkers for Prognostic Evaluation in iCCA PatientsYun Tao, Benjie Xu, Jie Tang, et al.
Frontiers in Immunology|November 18, 2024
Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancerJingjing Li, Qingqing Chen, Zhengcao Liu, et al.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology|July 2, 2016
[Hypoxia combined with TNF-α induces apoptosis of cultured human pulmonary microvascular endothelial cells via activation of the STAT3 rather than ERK1/2 signaling pathway]Shengjun Ji, Yeliang Wen, Qiting Lai, et al.
Translational Cancer Research|November 11, 2024
Retraction: Atorvastatin inhibits pancreatic cancer cells proliferation and invasion likely by suppressing neurotrophin receptor signalingShang Cai, Qingqing Chen, Yingying Xu, et al.
Scientific Reports|May 30, 2024
A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinomaShanshan Li, Zhengcao Liu, Qingqing Chen, et al.
World Journal of Surgical Oncology|February 21, 2024
Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinomaDanqi Qian, Peipei Shen, Jiahao Zhu, et al.
Discover Oncology|May 16, 2026
A multicenter study identifies an immune inflammatory and nutritional prognostic signature in intrahepatic cholangiocarcinomaJie Tang, Benjie Xu, Yun Tao, et al.
Annals of Medicine|April 3, 2025
Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patientsYingying Xu, Jinping Li, Xiang Ji, et al.
Pageof 6